...
首页> 外文期刊>Journal of cardiothoracic and vascular anesthesia >Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma
【24h】

Inhaled milrinone and epoprostenol in a patient with severe pulmonary hypertension, right ventricular failure, and reduced baseline brain saturation value from a left atrial myxoma

机译:患有严重肺动脉高压,右心衰竭和左心房粘液瘤的基线脑饱和度降低的患者,吸入米力农和依普司汀

获取原文
获取原文并翻译 | 示例

摘要

MYXOMAS ACCOUNT for approximately half of benign heart tumors.1 The signs and symptoms associated with myxomas are related closely to their size and location.1'2 Although large left-sided atrial myxomas may remain asymptomatic, they sometimes can be responsible for a spectrum of severe complications evolving from left atrial outflow obstruction, left ventricular failure, pulmonary hypertension (PHTN), and, rarely, right ventricular (RV) failure.1"3 The authors report the preemptive use of inhaled milrinone and epoprostenol for the intraoperative management of a patient with left atrial myxoma associated with severe PHTN and RV failure.
机译:粘液瘤约占良性心脏肿瘤的一半。1与粘液瘤相关的体征和症状与其大小和位置密切相关。1'2尽管大型左心房粘液瘤可能仍无症状,但有时可导致一系列严重的并发症包括左心房流出道梗阻,左心室衰竭,肺动脉高压(PHTN)以及极少的右心室(RV)衰竭。1“ 3作者报告了吸入性米力农和依泊汀在患者的术中管理中被优先使用。伴有严重PHTN和RV衰竭的左心室粘液瘤患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号